|
WO2004078163A2
(en)
|
2003-02-28 |
2004-09-16 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
|
US7531558B2
(en)
|
2003-02-14 |
2009-05-12 |
Glaxo Group Limited |
Carboxamide derivatives
|
|
WO2005016928A1
(ja)
|
2003-08-15 |
2005-02-24 |
Banyu Pharmaceutical Co., Ltd. |
イミダゾピリジン誘導体
|
|
JP2007518816A
(ja)
*
|
2004-01-23 |
2007-07-12 |
アムジエン・インコーポレーテツド |
バニロイド受容体リガンド及び炎症性及び神経因性疼痛の治療におけるこれらの使用
|
|
JP2007051121A
(ja)
*
|
2005-07-22 |
2007-03-01 |
Taiho Yakuhin Kogyo Kk |
プロスタグランジンｄ合成酵素を阻害するピリミジン化合物
|
|
DOP2006000210A
(es)
|
2005-10-04 |
2007-06-15 |
Aventis Pharma Inc |
Compuestos de pirimidina amida como inhibidores de pgds
|
|
AU2008245082B8
(en)
|
2007-04-24 |
2012-09-13 |
Shionogi & Co., Ltd. |
Aminodihydrothiazine derivatives substituted with a cyclic group
|
|
US8729263B2
(en)
|
2012-08-13 |
2014-05-20 |
Novartis Ag |
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
|
|
CA2913785C
(en)
|
2013-06-25 |
2021-08-31 |
F. Hoffmann-La Roche Ag |
Compounds for treating spinal muscular atrophy
|
|
JP6521995B2
(ja)
|
2014-02-20 |
2019-05-29 |
ユニヴァーシティー オブ ノートル ダム デュ ラック |
選択的マトリックスメタロプロテイナーゼ阻害剤
|
|
MX375925B
(es)
|
2014-06-25 |
2025-03-07 |
Hoffmann La Roche |
Compuestos imidazo[1,2-a]pirazin-1-il-benzamida para tratar atrofia muscular espinal.
|
|
WO2016187544A1
(en)
|
2015-05-20 |
2016-11-24 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and preventing cancer
|
|
CA3119019C
(en)
|
2015-12-10 |
2024-06-11 |
Ptc Therapeutics, Inc. |
Compounds and methods for treating huntington's disease
|
|
JP2018083799A
(ja)
|
2016-11-15 |
2018-05-31 |
バイオエレクトロン テクノロジー コーポレイション |
２−置換アミノ−ナフト［１，２−ｄ］イミダゾール−５−オン化合物またはその製薬学上許容される塩
|
|
JP2019535789A
(ja)
|
2016-11-28 |
2019-12-12 |
ピーティーシー セラピューティクス，インコーポレーテッド |
Ｒｎａスプライシングを調節する方法
|
|
EP4151627A1
(en)
|
2017-06-05 |
2023-03-22 |
PTC Therapeutics, Inc. |
Compounds for treating huntington's disease
|
|
CN111372611A
(zh)
|
2017-06-14 |
2020-07-03 |
Ptc医疗公司 |
修饰rna剪接的方法
|
|
CN111163838B
(zh)
|
2017-06-28 |
2023-03-28 |
Ptc医疗公司 |
用于治疗亨廷顿氏病的方法
|
|
CN111182898B
(zh)
|
2017-06-28 |
2024-04-16 |
Ptc医疗公司 |
用于治疗亨廷顿氏病的方法
|
|
MX2020001425A
(es)
|
2017-08-04 |
2020-08-06 |
Skyhawk Therapeutics Inc |
Metodos y composiciones para modular el empalme.
|
|
BR112020019373A2
(pt)
|
2018-03-27 |
2020-12-29 |
Ptc Therapeutics, Inc. |
Compostos para o tratamento da doença de hutington
|
|
KR20210038845A
(ko)
|
2018-06-27 |
2021-04-08 |
피티씨 테라퓨틱스, 인크. |
헌팅턴병 치료를 위한 헤테로아릴 화합물
|
|
WO2020005882A1
(en)
|
2018-06-27 |
2020-01-02 |
Ptc Therapeutics, Inc. |
Heteroaryl compounds for treating huntington's disease
|
|
IL279688B2
(en)
|
2018-06-27 |
2025-01-01 |
Ptc Therapeutics Inc |
Heterocyclic and heteroaryl compounds for the treatment of Huntington's disease
|
|
WO2020163248A1
(en)
|
2019-02-04 |
2020-08-13 |
Skyhawk Therapeutics, Inc. |
Methods and compositions for modulating splicing
|
|
CN113660936A
(zh)
|
2019-02-04 |
2021-11-16 |
斯基霍克疗法公司 |
用于调节剪接的方法和组合物
|
|
JP2022519637A
(ja)
|
2019-02-04 |
2022-03-24 |
スカイホーク・セラピューティクス・インコーポレーテッド |
スプライシングを調節するための方法および組成物
|
|
JP2022519296A
(ja)
|
2019-02-04 |
2022-03-22 |
スカイホーク・セラピューティクス・インコーポレーテッド |
スプライシングを調節するための方法および組成物
|
|
EP3920918A4
(en)
|
2019-02-05 |
2022-11-16 |
Skyhawk Therapeutics, Inc. |
METHODS AND COMPOSITIONS FOR MODULATION OF SPLICING
|
|
WO2020163401A1
(en)
|
2019-02-05 |
2020-08-13 |
Skyhawk Therapeutics, Inc. |
Methods and compositions for modulating splicing
|
|
WO2020163406A1
(en)
|
2019-02-05 |
2020-08-13 |
Skyhawk Therapeutics, Inc. |
Methods and compositions for modulating splicing
|
|
KR102913697B1
(ko)
|
2019-02-05 |
2026-01-15 |
스카이호크 테라퓨틱스, 인코포레이티드 |
스플라이싱을 조절하는 방법 및 조성물
|
|
WO2020163541A1
(en)
|
2019-02-05 |
2020-08-13 |
Skyhawk Therapeutics, Inc. |
Methods and compositions for modulating splicing
|
|
KR102925385B1
(ko)
|
2019-02-06 |
2026-02-11 |
스카이호크 테라퓨틱스, 인코포레이티드 |
스플라이싱을 조절하는 방법 및 조성물
|
|
JP7603594B2
(ja)
|
2019-02-06 |
2024-12-20 |
スカイホーク・セラピューティクス・インコーポレーテッド |
スプライシングを調節するための方法および組成物
|
|
WO2020167624A1
(en)
|
2019-02-13 |
2020-08-20 |
Ptc Therapeutics, Inc. |
Pyrrolo[2,3-d]pyrimidine compounds for treating familial dysautonomia
|
|
AU2020222881C1
(en)
|
2019-02-13 |
2026-01-22 |
Ptc Therapeutics, Inc. |
Thioeno(3,2-b) pyridin-7-amine compounds for treating familial dysautonomia
|
|
CA3139821A1
(en)
|
2019-05-13 |
2020-11-19 |
Ptc Therapeutics, Inc. |
Compounds for treating huntington's disease
|
|
WO2021007378A1
(en)
|
2019-07-11 |
2021-01-14 |
Ptc Therapeutics, Inc. |
Compounds for use in treating huntington's disease
|
|
TW202131920A
(zh)
|
2019-11-01 |
2021-09-01 |
瑞士商諾華公司 |
剪接調節子用於減慢杭丁頓氏舞蹈症進展的治療之用途
|
|
AU2021228285A1
(en)
|
2020-02-28 |
2022-09-29 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
CA3169697A1
(en)
|
2020-02-28 |
2021-09-02 |
Dominic Reynolds |
Thiophenyl derivatives useful for modulating nucleic acid splicing
|
|
AU2021228284A1
(en)
|
2020-02-28 |
2022-09-29 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
CA3169667A1
(en)
|
2020-02-28 |
2021-09-02 |
Dominic Reynolds |
Pyridazine derivatives for modulating nucleic acid splicing
|
|
CA3174353A1
(en)
|
2020-04-08 |
2021-10-14 |
Dominic Reynolds |
Compounds and methods for modulating splicing
|
|
MX2022012677A
(es)
|
2020-04-08 |
2023-01-11 |
Remix Therapeutics Inc |
Compuestos y metodos para modular el empalme.
|
|
MX2022012575A
(es)
|
2020-04-09 |
2023-01-24 |
Ptc Therapeutics Inc |
Compuestos para usarse para tratar la enfermedad de huntington.
|
|
WO2021231571A1
(en)
|
2020-05-13 |
2021-11-18 |
Chdi Foundation, Inc. |
Htt modulators for treating huntington's disease
|